Literature DB >> 27662447

Planning a Stigmatized Nonvisible Illness Disclosure: Applying the Disclosure Decision-Making Model.

Soe Yoon Choi1, Maria K Venetis2, Kathryn Greene1, Kate Magsamen-Conrad3, Maria G Checton4, Smita C Banerjee5.   

Abstract

This study applied the disclosure decision-making model (DD-MM) to explore how individuals plan to disclose nonvisible illness (Study 1), compared to planning to disclose personal information (Study 2). Study 1 showed that perceived stigma from the illness negatively predicted disclosure efficacy; closeness predicted anticipated response (i.e., provision of support) although it did not influence disclosure efficacy; disclosure efficacy led to reduced planning, with planning leading to scheduling. Study 2 demonstrated that when information was considered to be intimate, it negatively influenced disclosure efficacy. Unlike the model with stigma (Study 1), closeness positively predicted both anticipated response and disclosure efficacy. The rest of the hypothesized relationships showed a similar pattern to Study 1: disclosure efficacy reduced planning, which then positively influenced scheduling. Implications of understanding stages of planning for stigmatized information are discussed.

Entities:  

Keywords:  Efficacy; nonvisible illness; self-disclosure planning; stigma

Mesh:

Year:  2016        PMID: 27662447      PMCID: PMC5215027          DOI: 10.1080/00223980.2016.1226742

Source DB:  PubMed          Journal:  J Psychol        ISSN: 0022-3980


  15 in total

1.  An attribution model of public discrimination towards persons with mental illness.

Authors:  Patrick Corrigan; Fred E Markowitz; Amy Watson; David Rowan; Mary Ann Kubiak
Journal:  J Health Soc Behav       Date:  2003-06

2.  Self-disclosure in psychoanalytic-existential therapy.

Authors:  Jesse D Geller
Journal:  J Clin Psychol       Date:  2003-05

3.  Assessing health diagnosis disclosure decisions in relationships: testing the disclosure decision-making model.

Authors:  Kathryn Greene; Kate Magsamen-Conrad; Maria K Venetis; Maria G Checton; Zhanna Bagdasarov; Smita C Banerjee
Journal:  Health Commun       Date:  2011-10-12

4.  Decision making in cancer-related topic avoidance.

Authors:  Maria K Venetis; Kathryn Greene; Maria G Checton; Kate Magsamen-Conrad
Journal:  J Health Commun       Date:  2015-01-13

Review 5.  Self-disclosure: a literature review.

Authors:  P C Cozby
Journal:  Psychol Bull       Date:  1973-02       Impact factor: 17.737

Review 6.  Self-disclosing communication.

Authors:  W B Pearce; S M Sharp
Journal:  J Commun       Date:  1973-12

7.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

8.  Stigma of visible and invisible chronic conditions.

Authors:  G Joachim; S Acorn
Journal:  J Adv Nurs       Date:  2000-07       Impact factor: 3.187

9.  Communication Efficacy and Couples' Cancer Management: Applying a Dyadic Appraisal Model.

Authors:  Kate Magsamen-Conrad; Maria G Checton; Maria K Venetis; Kathryn Greene
Journal:  Commun Monogr       Date:  2015-06-01

10.  Self-disclosure and liking: a meta-analytic review.

Authors:  N L Collins; L C Miller
Journal:  Psychol Bull       Date:  1994-11       Impact factor: 17.737

View more
  3 in total

1.  Patient Decision-Making About Self-Disclosure of a Type 2 Diabetes Diagnosis: A Qualitative Study.

Authors:  Christy J W Ledford; Charisse Villareal; Elizabeth W Williams; Lauren A Cafferty; Jeremy T Jackson; Dean A Seehusen
Journal:  Diabetes Spectr       Date:  2022-01-25

Review 2.  Unravelling the Complexities of Workplace Disclosure Among Persons with Non-Visible Disabilities and Illnesses: A Qualitative Meta-Ethnography.

Authors:  Vanessa Tomas; Hiba Ahmed; Sally Lindsay
Journal:  J Occup Rehabil       Date:  2022-01-17

3.  "To die is better than to tell": reasons for and against disclosure of chronic hepatitis B status in Ghana.

Authors:  Charles Ampong Adjei; Sarah E Stutterheim; Florence Naab; Robert A C Ruiter
Journal:  BMC Public Health       Date:  2020-05-12       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.